Morgan Stanley’s Inclusive Ventures Lab (MSIVL), an accelerator dedicated to fostering technology and tech-enabled startups, recently welcomed its 10th cohort, which includes three UK-based women’s health startups: Juniver, Ovum, and HANX. These companies are working to address critical gaps in women’s healthcare, ranging from disordered eating and fertility to sexual and intimate wellness.
The Inclusive Ventures Lab was created to promote financial inclusion and offer early-stage capital to emerging tech startups. The five-month accelerator provides each selected company with a $250,000 investment, tailored mentorship, and access to Morgan Stanley’s broader network of partners. Since its inception in 2017, MSIVL has supported 117 companies, and this year’s cohort is the largest yet, with 25 startups from across the globe. With participants representing industries as diverse as fintech, healthcare, and sustainability, the program aims to help innovative businesses scale while addressing significant challenges in their…
